IUPAC Name : [(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butano (25122-57-0)
CAS: 25122-57-0
Synonyms: 11,20-Trione,21-chloro-9-fluoro-17-hydroxy-16-beta-methyl-pregna-4-diene-3 N ;21-Chloro-9-fluoro-17-hydroxy-16-beta-methylpregna-1,4-diene,3,11,20-trione ; Eumovate ; Molivate;Pregna-1,4-diene-3,11,20-trione,21-chloro-9-fluoro-16-methyl-17-(1-oxobutoxy ; Sn203 ; 21-chloro-9-fluoro-17-hydroxy-16beta-methylpregna-1,4-diene-3,11,20-trione 17-butyrate 
Molecular Formula  :C₂₆H₃₂ClFO₅
Molecular Weight  :478.99
EINECS: 246-635-9
MS:
Product Categories: Organics
Mol File: 25122-57-0.mol
Surface Tension: 47 dyne/cm
Density: 1.26 g/cm³ 
Flash Point: 181.1 °C 
Enthalpy of Vaporization: 85.92 kJ/mol 
Boiling Point: 573.3 °C at 760 mmHg 
Vapour Pressure: 3.78E-13 mmHg at 25°C 
Stability: Stable. Combustible. Incompatible with strong oxidizing agents.

1. Clobetasone butyrate (25122-57-0) is good for the treatment of congenital atopic dermatitis, face, neck, axilla, perineal eczema and other diseases.
2.Apply to affected area with ointment, 1, 1 ~ 3 times.
3. Clobetasone butyrate (25122-57-0) can cause local irritation, itching, acne, miliaria, white ringworm, etc. should be promptly disabled. 2. Large or long-term large-scale applications, there may be glucocorticoid side effects.

Hazard Codes:  Xn
Risk Statements:  40
40:  Limited evidence of a carcinogenic effect 
Safety Statements:  22-36
22:  Do not breathe dust 
36: Clobetasone butyrate (25122-57-0) used,please wear suitable protective clothing .
RTECS : TU4154083